Health Affairs | July 6, 2023
Read the PublicationMultiple lawsuits have now been brought that encompass a range of constitutional challenges to the Medicare Drug Price Negotiation Program enacted under the Inflation Reduction Act (IRA). More are expected to be filed by the pharmaceutical industry and their allies shortly.